Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Return on Assets (2022 - 2025)

InMed Pharmaceuticals' Return on Assets history spans 4 years, with the latest figure at 0.62% for Q4 2025.

  • For Q4 2025, Return on Assets rose 21.0% year-over-year to 0.62%; the TTM value through Dec 2025 reached 0.62%, up 21.0%, while the annual FY2025 figure was 0.6%, 0.0% changed from the prior year.
  • Return on Assets reached 0.62% in Q4 2025 per INM's latest filing, down from 0.57% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.42% in Q1 2024 to a low of 1.4% in Q3 2022.
  • Average Return on Assets over 4 years is 0.77%, with a median of 0.62% recorded in 2025.
  • Peak YoY movement for Return on Assets: skyrocketed 84bps in 2023, then crashed -51bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 1.08% in 2022, then soared by 55bps to 0.49% in 2023, then crashed by -72bps to 0.83% in 2024, then increased by 25bps to 0.62% in 2025.
  • Per Business Quant, the three most recent readings for INM's Return on Assets are 0.62% (Q4 2025), 0.57% (Q3 2025), and 0.66% (Q2 2025).